Due to the extremely significant diversity of all lung NET subtypes (based on clinical, histopathological or epidemiological differences), the selection of an appropriate therapeutic approach is an extremely difficult challenge for a multidisciplinary team of treating physicians including: gastroenterologist, pneumologist, endocrinologist, thoracic surgeons, pathologists, radiologists or nuclear medicine doctors, as well as oncological surgeons, clinical oncologists and radiation oncologists.
← all excerpts
The Role of Conventionally Fractionated Radiotherapy and Stereotactic Radiotherapy in the Treatment of Carcinoid Tumors and Large-Cell Neuroendocrine Cancer of the Lung.
1
—
—